Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13.8M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
5.73M
-
Shares change
-
-236K
-
Total reported value, excl. options
-
$32.4M
-
Value change
-
-$1.58M
-
Number of buys
-
7
-
Number of sells
-
-17
-
Price
-
$5.65
Significant Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q3 2019
36 filings reported holding CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share as of Q3 2019.
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.73M shares
of 13.8M outstanding shares and own 41.42% of the company stock.
Largest 10 shareholders include Battery Partners IX, LLC (2.01M shares), NEA Management Company, LLC (1.56M shares), VANGUARD GROUP INC (265K shares), CADENCE CAPITAL MANAGEMENT LLC (248K shares), RENAISSANCE TECHNOLOGIES LLC (185K shares), WELLS FARGO & COMPANY/MN (166K shares), DIMENSIONAL FUND ADVISORS LP (155K shares), ESSEX INVESTMENT MANAGEMENT CO LLC (138K shares), BlackRock Inc. (137K shares), and TOCQUEVILLE ASSET MANAGEMENT L.P. (135K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.